CLASS II Device recall · Reported 13 Jun 2018 · FDA Enforcement Report

St-aia Pack T4 recalled by Tosoh Bioscience

Tosoh Bioscience is recalling St-aia Pack T4, distributed nationwide in the US. The recall was initiated on 5 Mar 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll Lot Codes
Quantity recalled14690

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2079-2018
FDA event ID
79813
Recalling firm
Tosoh Bioscience, Grove City, OH
Classification
Class II
Status
Terminated
Recall initiated
5 Mar 2018
FDA classified
5 Jun 2018
Reported
13 Jun 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

5 Mar 2018Recall initiated by company
5 Jun 2018Classified by FDA+92 days
13 Jun 2018Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Asfotase Alfa (Strensiq) interferes with certain Tosoh assays which potentially causes falsely increased or falsely decreased immunoassay test results, depending upon the assay.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

ST-AIA PACK T4; Part Number: 025258 Assay, Thyroid

Where it was distributed

Worldwide Distribution: US (Nationwide) and countries of; Canada, Mexico, Columbia, Chile, Uruguay, Nicaragua, Argentina, Peru, Chile, Honduras. Equador, Caymen Islands, Panama, and Costa Rica.

Nationwide

Questions about this recall

Is St-aia Pack T4 recalled?

Yes. Tosoh Bioscience recalled St-aia Pack T4 on 5 Mar 2018. The recall is Class II and its status is Terminated. Recall number Z-2079-2018.

Why was it recalled?

Asfotase Alfa (Strensiq) interferes with certain Tosoh assays which potentially causes falsely increased or falsely decreased immunoassay test results, depending upon the assay.

Which lots are affected?

All Lot Codes

Where was it sold?

Worldwide Distribution: US (Nationwide) and countries of; Canada, Mexico, Columbia, Chile, Uruguay, Nicaragua, Argentina, Peru, Chile, Honduras. Equador, Caymen Islands, Panama, and Costa Rica.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Tosoh Bioscience

All 74

Other Test Kits & Diagnostics recalls

All 2,656